Cabotegravir

Overview

Cabotegravir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2403238).

API suppliers (3)

Suppliers of Cabotegravir backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• Cipla USA, Inc.USA1 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Cabotegravir expires 15 Sept 2031 and exclusivity 21 Jan 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(3R,6S)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-6-methyl-8,11-dioxo-4-oxa-1,7-diazatricyclo[7.4.0.03,7]trideca-9,12-diene-12-carboxamide

Canonical SMILES

C[C@H]1CO[C@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O

InChIKey

WCWSTNLSLKSJPK-LKFCYVNXSA-N